Dr Faye Cooles Gemma Vidal Pedrola Najib Naamane Dr Arthur Pratt Dr Ben Barron-Millar et al. | Endogenous Retroelement Activation is Implicated in Interferon-α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis | 2025 |
|
Philip Brown Dr Amy Anderson Najib Naamane Dr Dennis Lendrem Professor John Isaacs et al. | Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritis | 2024 |
|
Dr Abi Gault Dr Linda Hogarth Dr Kristian Williams Professor Alastair Greystoke Professor Neil Rajan et al. | Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study | 2024 |
|
Dr Ken Baker Dr David McDonald Dr Gill Hulme Raf Hussain Dr Jonathan Coxhead et al. | Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission | 2024 |
|
Professor Catharien Hilkens Julie Diboll Dr Fiona Cooke Dr Amy Anderson
| In vitro generation of human tolerogenic monocyte-derived dendritic cells | 2023 |
|
Gemma Vidal Pedrola Najib Naamane Dr Arthur Pratt Emeritus Professor Andrew Mellor Professor John Isaacs et al. | Characterization of age-associated B cells in early drug-naïve rheumatoid arthritis patients | 2023 |
|
Dr Kristian Williams Abigail Gault Dr Amy Anderson Professor Christopher Stewart Professor Chris Lamb et al. | Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations | 2023 |
|
Dr Fiona Cooke Dr Mary Neal Dr Matthew Wood Dr Amy Anderson Julie Diboll et al. | Fluorine labelling of therapeutic human tolerogenic dendritic cells for 19F-magnetic resonance imaging | 2022 |
|
Dr Faye Cooles Jessica Tarn Dr Dennis Lendrem Najib Naamane Alice Lin et al. | Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming | 2022 |
|
Professor John Isaacs Sarah Brockbank Dr Ayako Pedersen Professor Catharien Hilkens Dr Amy Anderson et al. | RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients | 2022 |
|
Dr Fiona Rayner Dr Amy Anderson Dr Ken Baker Professor Christopher Buckley Dr Bernard Dyke et al. | BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study | 2021 |
|
Dr Nicola Maney Dr Ben Barron-Millar Dr Christopher Carey Ian Herron Dr Amy Anderson et al. | Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis | 2021 |
|
Alex Clark Dr Amy Anderson Dr Nishanthi Thalayasingam Najib Naamane Julie Diboll et al. | Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease loci | 2020 |
|
Dr Amy Anderson Dr Nicola Maney Dr Dennis Lendrem Julie Diboll Dr Philip Brown et al. | Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis | 2019 |
|
Laura Ridgley Dr Amy Anderson Dr Nicola Maney Najib Naamane Andrew Skelton et al. | IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function | 2019 |
|
Dr Rachel Spiering Matthew Wood Anshor Fath Oliver Eltherington Dr Amy Anderson et al. | Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis | 2019 |
|
Dr Nishanthi Thalayasingam Andrew Skelton Dr Amy Anderson Alex Clark Julie Diboll et al. | CD4+ and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in untreated early arthritis: implications for causal gene identification | 2018 |
|
Dr Faye Cooles Dr Amy Anderson Andrew Skelton Dr Arthur Pratt Professor Iain McInnes et al. | Phenotypic and transcriptomic analysis of peripheral blood plasmacytoid and conventional dendritic cells in early drug naïve rheumatoid arthritis | 2018 |
|
Laura Ridgley Dr Amy Anderson Dr Arthur Pratt
| What are the dominant cytokines in early rheumatoid arthritis? | 2018 |
|
Dr Gillian Bell Dr Amy Anderson Julie Diboll Oliver Eltherington Dr Rachel Harry et al. | Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis | 2017 |
|
Dr Amy Anderson
| Increased Expression of Cytotoxic T-Lymphocyte−Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure | 2017 |
|
Dr Faye Cooles Dr Amy Anderson Dr Dennis Lendrem Julie Norris Dr Arthur Pratt et al. | The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy | 2017 |
|
Dr Amy Anderson Dr David Swan Oliver Eltherington Dr Arthur Pratt Dr Gary Reynolds et al. | Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4+ T-cells partly via TGF-β1 | 2017 |
|
Dr Arthur Pratt Dr Amy Anderson Professor John Isaacs
| Bcl-3 in CD4+ T Cell–Mediated Rheumatoid Arthritis Pathogenesis: Comment on the Article by Meguro et al | 2016 |
|
Dr Arthur Pratt Dr Amy Anderson Professor John Isaacs Julie Diboll Dr Nishanthi Thalayasingam et al. | Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23 | 2016 |
|
Dr Arthur Pratt Dr Amy Anderson Julie Diboll Andrew Skelton Dr Dennis Lendrem et al. | Identification of novel expression quantitative trait loci in CD4+ T cells of untreated early arthritis patients | 2016 |
|
Dr Amy Anderson Dr Arthur Pratt Dr John Doran Christine Routledge Ben Hargreaves et al. | IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anti-citrullinated peptide antibody-negative rheumatoid arthritis | 2016 |
|
Dr Faye Cooles Dr Amy Anderson Dr Rachel Harry Julie Diboll Lee Munro et al. | Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies | 2016 |
|
Dr Phillip Lord Dr Rachel Spiering Dr Amy Anderson Julie Diboll Emeritus Professor Lindsay Marshall et al. | Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies | 2016 |
|
Dr Amy Anderson
| Adaptive Immune Reponses in ALF | 2015 |
|
Dr Amy Anderson Dr Carmen Martin-Ruiz Professor Dawn Teare
| RIPOSTE: a framework for improving the design and analysis of laboratory-based research | 2015 |
|
Dr Arthur Pratt Dr Amy Anderson Dr Dennis Lendrem Julie Diboll Ben Hargreaves et al. | STAT3-regulated gene expression in circulating CD4+ T cells discriminates RA patients independently of clinical parameters in early arthritis: a validation study. | 2015 |
|
Dr Arthur Pratt Dr Amy Anderson Julie Diboll Andrew Skelton Ben Hargreaves et al. | The Importance of IL-6-STAT3 Mediated Activation of Circulating CD4+ T Cells in the Pathogenesis of Early Seronegative Rheumatoid Arthritis: A Validation Study | 2015 |
|
Dr Faye Cooles Dr Amy Anderson Professor Catharien Hilkens Professor John Isaacs
| The Interferon Gene Signature in Early Rheumatoid Arthritis Demonstrates No Significant Association with Disease Activity | 2015 |
|
Harriet Purvis Dr Amy Anderson Professor David Young Professor John Isaacs Professor Catharien Hilkens et al. | A Negative Feedback Loop Mediated by STAT3 Limits Human Th17 Responses | 2014 |
|
Marilena Patsalidou Dr Amy Anderson Dr Anja Krippner-Heidenreich
| An unconventional anti-inflammatory role for TNF recpetor (TNFR)1 in tregs: TNFR1 and 2 differetnialy modulate FOXP3+ TREG function | 2014 |
|
Dr Gillian Bell Dr Amy Anderson Julie Diboll Dr Rachel Harry Emerita Professor Elaine McColl et al. | Autologous Tolerogenic Dendritic Cells for Rheumatoid and Inflammatory Arthritis. | 2014 |
|
Dr Gillian Bell Dr Amy Anderson Dr Rachel Harry Julie Diboll Emerita Professor Elaine McColl et al. | Autologous tolerogenic dendritic cells in rheumatoid and inflammatory arthritis | 2014 |
|
Dr Amy Anderson Christine Routledge Professor John Isaacs Dr Arthur Pratt
| Investigation of interleukin-6-driven STAT3 signalling in circulating lymphocytes of patients with early rheumatoid arthritis as a route to biomarker discovery | 2014 |
|
Dr Amy Anderson Dr Arthur Pratt Ben Hargreaves Philip Brown Professor John Isaacs et al. | Phospho-STAT1/3 and Gene Expression Measurement in Circulating CD4+ T Cells As Diagnostic Tools in Early Autoantibody-Negative Rheumatoid Arthritis | 2014 |
|
Dr Amy Anderson Dr Arthur Pratt Ben Hargreaves Philip Brown Professor John Isaacs et al. | Phospho-STAT1/3 measurement in circulating CD4+T-cells as a diagnostic tool in early autoantibody-negative rheumatoid arthritis | 2014 |
|
Dr Gillian Bell Dr Amy Anderson Julie Diboll Dr Rachel Harry Emerita Professor Elaine McColl et al. | Autologous Tolerogenic Dendritic Cells In Rheumatoid and Inflammatory Arthritis | 2013 |
|
Dr Amy Anderson Christine Routledge Phil Mawson Professor John Isaacs Dr Arthur Pratt et al. | Interleukin-6 driven STAT3 phosphorylation in circulating lymphocytes is specific for CD4 T cells in early rheumatoid arthritis | 2013 |
|
Dr Amy Anderson Christine Routledge Phil Mawson Professor John Isaacs Dr Arthur Pratt et al. | Interleukin-6 Driven STAT3 Phosphorylation In Circulating Lymphocytes Is Specific For CD4+ T Cells In Early Rheumatoid Arthritis | 2013 |
|
Dr Faye Cooles Professor John Isaacs Dr Amy Anderson
| Treg Cells in Rheumatoid Arthritis: An Update | 2013 |
|
Dr Gillian Bell Dr Amy Anderson Dr Rachel Harry Dr Jeroen Stoop Professor Catharien Hilkens et al. | Autologous tolerogenic dendritic cells in rheumatoid arthritis | 2012 |
|
Harriet Purvis Dr Amy Anderson Professor Catharien Hilkens
| Human T helper 17 responses: the effect of T-cell density | 2012 |
|
Dr Amy Anderson Dr Alice Lorenzi Dr Arthur Pratt Thomas Wooldridge Julie Diboll et al. | Immunity 12 years after alemtuzumab in RA: CD5+ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses | 2012 |
|
Harriet Purvis Dr Amy Anderson Professor Catharien Hilkens
| Human Th17 responses: the effect of T-cell density | 2011 |
|
Dr Malcolm Brodlie Dr Michael McKean Dr Amy Anderson Professor Catharien Hilkens Professor Andrew Fisher et al. | Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease | 2011 |
|
Dr Rachel Harry Dr Amy Anderson Professor John Isaacs Professor Catharien Hilkens
| Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis | 2010 |
|
Harriet Purvis Dr Jeroen Stoop Professor Jelena Mann Steven Woods Anne Kozijn et al. | Low strength T-cell activation promotes Th17 responses | 2010 |
|
Dr Jeroen Stoop Professor Jelena Mann Steven Woods Anne Kozijn Professor Sophie Hambleton et al. | Low-strength T-cell activation promotes Th17 responses | 2010 |
|
Dr Amy Anderson Dr David Swan Bethan Sayers Dr Rachel Harry Dr Angela Patterson et al. | LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells | 2009 |
|
Professor John Isaacs Dr Amy Anderson
| Regulatory T cells and autoimmunity | 2009 |
|
Dr Amy Anderson
| Seasonal changes in suppressive capacity of CD4 CD25 T cells from patients with hayfever are allergen-specific and may result in part from expansion of effector T cells among the CD25 population | 2009 |
|
Dr Alice Lorenzi Dr Amy Anderson Dr Jonathan Catterall Dr Angela Patterson Emerita Professor Helen Foster et al. | Thymic function in juvenile idiopathic arthritis | 2009 |
|
Dr Rachel Harry Dr Amy Anderson Dr Graham Raftery Professor John Isaacs Professor Catharien Hilkens et al. | Development of clinical-grade tolerogenic dendritic cells for the treatment of rheumatoid arthritis | 2008 |
|
Dr Amy Anderson Bethan Sayers Professor Muzlifah Haniffa Dr David Swan Julie Diboll et al. | Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells | 2008 |
|
Dr Alice Lorenzi Dr Amy Anderson Dr Jonathan Catterall Dr Angela Patterson Emerita Professor Helen Foster et al. | Thymic function in juvenile idiopathic arthritis | 2008 |
|
Dr Amy Anderson Bethan Sayers Dr David Swan Professor John Isaacs Professor Catharien Hilkens et al. | Tolerogenic dendritic cell therapy for rheumatoid arthritis | 2008 |
|
Dr Amy Anderson Professor John Isaacs
| Tregs and rheumatoid arthritis | 2008 |
|
Dr Amy Anderson
| TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: Results from a genome-wide scan | 2007 |
|
Dr Amy Anderson
| Helicobacter infection in the surfactant protein D-deficient mouse | 2007 |
|
Dr Amy Anderson Bethan Sayers Julie Diboll Professor John Isaacs Professor Catharien Hilkens et al. | Tolerogenic dendritic cells differentially modulate naïve and memory CD4+ T cells | 2007 |
|